EVP-6308
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EVP-6308, covering 2014-10-10 to 2015-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics [Phase 1]